Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II TrialNeoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenocarcinoma, carcinoma, epithelial neoplasm, lung adenocarcinoma, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 22026-09-17NCT04105270

1 results · Page 1 of 1

Swipe the table sideways for more columns.

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Dr. Amit KulkarniPhoenixUnited States1
Masonic Cancer Center, University of MinnesotaMinneapolisUnited States15
MNCCTN Essentia Health Deer RiverDeer RiverUnited States1
MNCCTN Essentia Health DuluthDuluthUnited States1
MNCCTN Essentia Health FosstonFosstonUnited States1
MNCCTN Essentia Health Hibbing ClinicHibbingUnited States1
MNCCTN Essentia Health SandstoneSandstoneUnited States1
MNCCTN Essentia Health St. Joseph's Brainerd Medical CenterBrainerdUnited States1
MNCCTN Essentia Health St. Mary's Detroit Lakes ClinicDetroit LakesUnited States1
MNCCTN Essentia Health Virginia ClinicVirginiaUnited States1